 |
Previous Article | Next Article 
The Journal of Neuroscience, June 15, 2002, 22(12):4869-4877
Cyclin-Dependent Kinase 5 Phosphorylates Disabled 1 Independently
of Reelin Signaling
Lakhu
Keshvara,
Susan
Magdaleno,
David
Benhayon, and
Tom
Curran
Department of Developmental Neurobiology, St. Jude Children's
Research Hospital, Memphis, Tennessee 38105
 |
ABSTRACT |
Two major signaling pathways that control neuronal positioning
during brain development have been uncovered as a result of genetic and
biochemical studies on neurological mouse mutants. Mice deficient in
Reelin, Disabled 1 (Dab1), or both the very low-density lipoprotein
receptor (VLDLR) and the apolipoprotein E receptor 2 (ApoER2) exhibit
identical neuroanatomic defects in laminar structures throughout the
brain. These proteins function as components of the Reelin signaling
pathway. Reelin is a secreted glycoprotein that binds to VLDLR and
ApoER2, inducing tyrosine phosphorylation of Dab1, an intracellular
adapter protein. Neuronal migration is also regulated by
cyclin-dependent kinase 5 (Cdk5) and its activating subunits p35 and
p39. Mice deficient in Cdk5, p35, or both p35 and p39 exhibit
lamination defects that are similar but not identical to those observed
in mice with a defect in the Reelin signaling pathway. Cdk5
phosphorylates proteins that maintain cytoskeletal structures and
promote cell motility. To explore the possibility that Cdk5 influences
the Reelin pathway, we sought to determine whether Dab1 is a substrate
for Cdk5. Here we show that Cdk5 phosphorylates Dab1 on serine 491 in vitro and in vivo, independently of
Reelin signaling. We also show that ectopic neurons in Cdk5-deficient
mice exhibit reduced levels of Reelin signaling during later stages of
cortical development, although Cdk5 is not required for Reelin-induced
tyrosine phosphorylation of Dab1. Although the functional significance
of Dab1 serine phosphorylation is unclear, our results suggest that
there is biochemical cross-talk between two signaling pathways that
control cell positioning.
Key words:
reeler; neuronal migration; Reelin; VLDLR; ApoER2; Dab1; Cdk5; p35; p39; phosphorylation; signal transduction
 |
INTRODUCTION |
Analysis of neurological mutant mice
has led to the identification of several genes that are critical for
neuronal positioning during development of the mammalian brain (Rice
and Curran, 2001 ). One of the most widely studied neurological mutants
is the ataxic mouse reeler, which carries a disruption in
the gene encoding Reelin, a large secreted glycoprotein (D'Arcangelo
et al., 1995 ). In the absence of Reelin, neurons fail to assume correct
positions within the developing brain, resulting in severe defects in
lamination of brain structures, including the cerebral cortex,
cerebellum, and hippocampus (for review, see D'Arcangelo and Curran,
1998 ). Identical defects were later described in mice deficient in
Disabled 1 (Dab1), or both very low-density lipoprotein receptor
(VLDLR) and apolipoprotein E receptor 2 (ApoER2), providing strong
evidence that these proteins participate in the Reelin signaling
pathway (Howell et al., 1997b ; Sheldon et al., 1997 ; Trommsdorff et
al., 1999 ). Mice lacking cyclin-dependent kinase 5 (Cdk5), p35, or both
p35 and p39 exhibit lamination defects that are similar but not
identical to those observed in reeler (Ohshima et al., 1996 ; Chae et al., 1997 ; Gilmore et al., 1998 ; Kwon and Tsai, 1998 ; Ko et
al., 2001 ). In contrast to the situation in reeler, initial waves of migrating neurons in
Cdk5 / mice successfully split
the preplate, but subsequent migration failures result in inversion of
layers beneath an ectopic subplate. Therefore, Cdk5 is thought to be a
component of a signaling pathway distinct from the Reelin pathway.
The phosphotyrosine-binding (PTB) domain of Dab1 associates with an
NPxY motif in the cytoplasmic region of VLDLR and ApoER2 (Trommsdorff
et al., 1998 ). Reelin binds to these receptors on the surface of
neurons, triggering tyrosine phosphorylation of Dab1 (D'Arcangelo et
al., 1999 ; Hiesberger et al., 1999 ; Howell et al., 1999a ). In the
absence of Reelin or the receptors, Dab1 accumulates in a
hypophosphorylated form (Rice et al., 1998 ; Trommsdorff et al., 1999 ).
Tyrosine phosphorylated Dab1 may couple Reelin signaling to downstream
molecular machinery involved in cell positioning. Thus, Dab1 could
serve as a nexus for numerous signaling pathways.
Cdk5 is a serine-threonine kinase that is ubiquitously expressed, but
its catalytic activity is dependent on the neuronal regulators p35 or
p39 (Tsai et al., 1993 , 1994 ; Lew et al., 1994 ; Tang et al., 1995 ).
Cdk5 phosphorylates a variety of substrates in vitro,
including proteins known to play a role in cell adhesion and migration
(for review, see Dhavan and Tsai, 2001 ). One possible way in which Cdk5
can influence Reelin signaling is through phosphorylation of Dab1. We
showed previously that Dab1 is phosphorylated predominantly on
serine-threonine residues in a transient transfection system (Homayouni et al., 1999 ). Indeed, Dab1 contains numerous potential phosphorylation sites for Cdk5. Here we show that Cdk5 phosphorylates serine 491 of Dab1 in vitro, as well as in vivo.
Unlike tyrosine phosphorylation, serine phosphorylation of Dab1 occurs
independently of Reelin signaling. Furthermore, Cdk5 is not required
for Reelin-induced tyrosine phosphorylation of Dab1. Thus, although
these phosphorylation events are governed by two distinct pathways, our
results raise the possibility that Cdk5 modulates Reelin signaling
downstream of Dab1.
 |
MATERIALS AND METHODS |
Materials. The Dab1-hemagglutinin (Dab1-HA)
expression plasmid and the glutathione S-transferase
(GST) fusion constructs containing full-length Dab1 or Dab1
domains have been described previously (Keshvara et al., 2001 ). Cdk5
and p35 expression plasmids were provided by Dr. Li-Huei Tsai (Harvard
Medical School, Boston, MA). Site-directed mutagenesis was conducted
using the QuikChange site-directed mutagenesis kit (Stratagene, La
Jolla, CA). Purified polyhistidine-tagged Dab1 (Dab1-His) was provided
by Dr. Hee-Won Park (St. Jude Children's Research Hospital). Anti-Cdk5
antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz,
CA). Rabbit anti-Dab1 antibodies (CT38) raised against the C terminal region of Dab1 and goat anti-Dab1 PTB have been described previously (Keshvara et al., 2001 ). B3 anti-Dab1 antibodies were a gift from Dr.
Jonathan Cooper (Fred Hutchinson Cancer Research Center, Seattle, WA).
Phosphopeptide antibodies. Synthesis of the phosphopeptide
PSer491 [TPAPRQSS(PO4)PSKSSA] and chemical
coupling to KLH or Sepharose were performed by Hartwell Center for
Bioinformatics and Biotechnology (St. Jude Children's Research
Hospital). Immunization and antibody production were performed by
Rockland (Gilbertsville, PA). Antisera were screened by Western
blotting using lysates of human embryonic kidney 293 (HEK293T)
cells transfected with Dab1 and Cdk5/p35.
Antibody purification. To purify anti-PSer491, 250 µl of
antiserum was diluted with PBS and passed several times through a column containing 500 µl of PSer491-Sepharose slurry (~5 mg of phosphopeptide). After washing the column with PBS, bound
antibodies were eluted with 100 mM glycine, pH
2.8. The eluate was neutralized with 1 M
Tris-HCl, pH 9, and dialyzed against PBS. For the purification of
anti-Dab1 PTB antibodies, 10 mg of purified GST-PTB was coupled to
Sepharose using AminoLink Plus Immobilization kit (Pierce, Rockford,
IL). Goat anti-PTB antisera were diluted with PBS and passed through
this column several times, and the bound antibodies were eluted as
above. The antibodies were further purified by passing once over
GST-Sepharose column (Pierce).
Protein expression. GST fusion proteins were expressed in
BL21 bacterial strains (Stratagene) as described previously (Keshvara et al., 2001 ). Briefly, bacteria were grown in LB media and
induced with 100 µM
-D-galactopyranoside for 4 hr at 37°C.
Bacterial pellets were lysed by sonicating in PBS containing 1% Triton
X-100, 5 mM EDTA, 2 mM
phenylmethylsulfonyl fluoride, 40 µg/ml aprotinin, and 40 µg/ml
leupeptin. The lysates were incubated with glutathione-Sepharose (Amersham Biosciences, Piscataway, NJ) at 4°C. Bound proteins were
eluted with 15 mM glutathione and dialyzed in 50 mM Tris-HCl, pH 7.5.
Animal genotyping and dissection. Reeler,
Cdk5 mutant, and wild-type mice were used. Conception was
determined by the presence of a vaginal plug, with the day of
conception considered to be embryonic day 0 (E0). Cdk5
mutant embryos and wild-type littermates were generated by crossing
Cdk5 heterozygotes. Genotyping was accomplished by PCR using
the following oligonucleotide primers: 5'-tcatgagattgtggctctgaag;
5'-tcttgtcactatgcaggacatc; and 5'-gcatgctccagactgccttg. Embryonic and
adult brains were removed by dissection and were either snap frozen in
liquid nitrogen or triturated for tissue culture. Reeler
embryos were generated by crossing homozygous reeler mice.
Immunohistochemical analysis. Embryos from E15.5 to E17.5
were delivered surgically and perfused intracardially with 4%
paraformaldehyde in 0.1 M PBS, pH 7.2. The tissue
was postfixed for 4 hr at 4°C, cryoprotected in 25% sucrose,
embedded in TBS tissue freezing medium (Triangle Biomedical Sciences,
Durham, NC) on dry ice, and processed using standard techniques (Rice
et al., 1998 ). For all experiments, control and test tissues were
embedded together in one block to minimize differences in section
thickness. Colocalization of Cdk5 and Dab1 was performed using rabbit
anti-Cdk5 antibodies (1:100) (Santa Cruz Biotechnology) and goat
anti-Dab1 antibodies (1:100). Nonspecific antibody binding was blocked
with 2.5% BSA in PBS, pH 7.3, containing 0.01% Triton X-100 (PBST)
for 1 hr at room temperature. For double staining, goat anti-Dab1 and
rabbit anti-Cdk5 antibodies were diluted together in BSA-PBST and
incubated with tissue sections at 4°C overnight. Tissue sections were
washed thoroughly in PBS and then incubated with Alexa-Fluor
594-conjugated donkey anti-goat IgG (1:200) and AlexaFluor
488-conjugated goat anti-rabbit IgG (1:200) (Molecular Probes, Eugene,
OR) for 1 hr at room temperature. Sections were washed as described
above, and coverslips were mounted with Vectashield Mounting Medium
(Vector Laboratories, Burlingame, CA). Adjacent sections identically
processed without the primary antibody did not show any significant
staining above background (data not shown).
Embryonic day 18.5 sagittal sections from
Cdk5+/+ and
Cdk5 / brains were incubated in a humid
chamber overnight at 4°C with rabbit anti-Dab1 antibodies (B3;
1:800). Rabbit anti-Dab1 antibodies were detected using the Vectastain
Elite ABC kit (Vector Laboratories) as described previously (Rice et
al., 1998 ). Cdk5+/+ and
Cdk5 / tissues were cut and slide
mounted in the same tissue block and incubated for equivalent times in
diaminobenzidine (DAB) substrate (Kirkegaard & Perry, Gaithersburg,
MD). As negative controls, adjacent sections from the same tissue block
were identically processed without the primary antibody, and no DAB
reaction product was observed (data not shown). Slides were dehydrated
and mounted by standard techniques. Immunofluorescence and
immunohistochemical detection of Dab1 and Cdk5 were performed using an
Olympus BX60 upright microscope, and images were acquired with a
Hamamatsu (Bridgewater, NJ) C5810 video camera and imported directly
into Adobe Photoshop 5.0 (Adobe Systems, San Jose, CA). Images of Dab1 and Cdk5 double staining of postnatal day 7 (P7) cerebellum were acquired using a Leica (Nussloch, Germany) TCS confocal laser scanning
microscope equipped with a 100× oil objective. Contrast and brightness
were applied equally to each figure to obtain high-quality photomicrographs.
Reelin stimulation and brain lysates. Stimulation of
embryonic neurons with purified Reelin has been described previously (Keshvara et al., 2001 ). Briefly, neurons obtained by trituration of
embryonic brains were treated with either purified recombinant Reelin
or a control supernatant for 15 min at 37°C. After incubation, neurons were either snap frozen or lysed immediately. Reelin-treated neuronal pellets were lysed in cell lysis buffer (25 mM Tris-HCl, 1% Nonidet P-40, 150 mM NaCl, 5 mM EDTA, 1 mM sodium orthovanadate, 20 mM sodium fluoride, and 20 µg/ml each of
aprotinin and leupeptin). Whole brains were also homogenized in this
lysis buffer. Cell lysates as well as brain homogenates were clarified
by centrifugation at 10,000 × g at 4°C for 20 min.
Cell culture and transfection. HEK293T cells (American Type
Culture Collection, Manassas, Virginia) were maintained in DMEM (BioWhittaker, Walkersville, MD) supplemented with 10% fetal bovine serum (BioWhittaker), 10 U/ml penicillin-streptomycin mixture (BioWhittaker), and 2 mM GlutaMAX (Invitrogen,
Carlsbad, CA). Transfections were performed using FuGene 6 transfection
reagent (Roche Molecular Biochemicals, Indianapolis, IN). Twenty-four hours after transfection, cells were lysed in cell lysis buffer.
Immunoprecipitation and Western blotting. Cell or brain
lysates were incubated with anti-Cdk5 or anti-Dab1 antibodies for 4°C
for 2 hr. Immune complexes were collected with protein G-agarose beads
(Pierce) and washed three times with cell lysis buffer. Immunoprecipitates were boiled in SDS sample buffer, separated by
SDS-PAGE, and blotted to nitrocellulose membranes. Nitrocellulose membranes were blocked with 5% nonfat dry milk in TBST (50 mM Tris, pH 7.4, 150 mM
NaCl, and 1% Tween 20) for 1 hr at room temperature. The following
antibodies were used for various immunoblots: anti-PSer491 (1:1000),
anti-Cdk5 (1:2000), anti-PY198 (1:100), 4G10 (1:2000) (Upstate
Biotechnology, Lake Placid, NY), and anti-Dab1 (CT38; 1:5000). All
dilutions were made in blocking solution, and incubations were
performed at room temperature for 1 hr. The membranes were washed in
TBST and incubated with horseradish peroxidase-conjugated secondary
antibody (1:10,000) for 1 hr. Detection was performed using Super
Signal West Dura Extended Duration Substrate (Pierce).
In vitro kinase assay. For kinase assays, anti-Cdk5
immunoprecipitates were washed three times with cell lysis buffer and once with 25 mM Tris-HCl, pH 7.5. The beads were
then incubated with a kinase reaction mixture containing 5 µg of
substrate (GST fusions or Dab1-His), 10 mM
MgCl2, and 10 µCi of ATP (10 µM) in 25 mM Tris-HCl, pH
7.5. The reactions were performed at 30°C for 15 min and then stopped
by boiling in SDS sample buffer. Phosphorylated proteins were separated
by SDS-PAGE, transferred to nitrocellulose membranes, and detected by
autoradiography. Membranes were stained with Coomassie brilliant blue
to locate the proteins before trypsinization.
Phosphopeptide mapping. Phosphoproteins were excised from
nitrocellulose membranes and digested with trypsin (Promega, Madison, WI) as described previously (Keshvara et al., 2001 ). Phosphopeptides were dried and separated by electrophoresis on an alkaline 40% polyacrylamide gel as described previously (Keshvara et al., 2001 ). After the tracking dye had migrated to
RF = 0.5, the gel was dried, and
phosphopeptides were detected by autoradiography.
 |
RESULTS |
Dab1 and Cdk5 are coexpressed in the developing brain
Mice that lack Dab1 or Cdk5 exhibit defects in the migration
patterns of neurons in the cortical plate and in the cerebellum. However, the defective migration of neurons in Cdk5-deficient mice is
distinct from the abnormal migrations observed in Dab1-deficient mice.
During early corticogenesis, Dab1 is present in the cells that occupy
the ventricular zone during the preplate stage of development, and
later it is present in migrating neurons in the intermediate zone and
in neurons within the cortical plate (Fig. 1A) (Rice et al.,
1998 ). Cdk5 is detected as early as E14.5 in postmitotic neurons in the
cerebral cortex (Tsai et al., 1993 ), and it is predominantly present in
thalamocortical tracts (Fig. 1B). In P0 cerebellum,
Dab1 is expressed in Purkinje cells as they migrate to form the
Purkinje cell layer (Fig. 1D). Cdk5 is expressed in
Purkinje cells in the cerebellum, but it is also present in large cells
of the cerebellar cortex, such as the basket, Lugaro, or Golgi cells
(Ohshima et al., 1999 ) (Fig. 1E). Confocal microscopy
of postnatal day 7 cerebellum shows expression of both Dab1 and Cdk5
within cell bodies and dendrites of individual Purkinje cells as they
migrate to form the Purkinje cell layer in the developing cerebellum
(Fig. 1G-I). Therefore, because these analyses show that Dab1 and Cdk5 are present in overlapping cell populations in the
cerebral cortex and in Purkinje cells of the cerebellum (Fig.
1C,F,I), it is
possible that Cdk5 phosphorylates Dab1 directly in
vivo.

View larger version (127K):
[in this window]
[in a new window]
|
Figure 1.
Dab1 and Cdk5 display distinct but overlapping
expression patterns in the cerebral cortex and cerebellum at postnatal
day 0. A, Dab1 (red) is present in the
cell bodies and dendritic processes of neurons in the cerebral cortex.
B, Cdk5 (green) is detected in
postmitotic neurons in the cortical plate and in the thalamocortical
fibers. C, Double staining shows that Dab1 and Cdk5
expression overlap in postmitotic neurons in the cerebral cortex.
D, In the cerebellum, Dab1 is expressed in Purkinje
cells as they migrate to form the Purkinje cell layer.
E, Cdk5 is expressed in Purkinje cells, but it is also
present in cerebellar nuclei and in axon tracts in the cerebellum.
F, Double staining shows that Dab1 and Cdk5 overlap in
the Purkinje cells of the developing cerebellum
(yellow). Scale bar (in F),
~100 µm. G, Dab1 is present in Purkinje cell bodies
and dendrites in the postnatal day 7 cerebellum. H, Cdk5
is also present in Purkinje cell bodies and dendrites.
I, Double staining in the same tissue section shows the
overlap of Dab1 and Cdk5 expression in Purkinje cells.
Arrows point out individual Purkinje cells in the
overlay image. Scale bar (in I), ~10 µm.
mz, Marginal zone; cp, cortical plate;
wm, white matter; egl, external germinal
layer; pcl, Purkinje cell layer.
|
|
Cdk5 Phosphorylates Dab1 in vitro
To determine whether Cdk5 can phosphorylate Dab1 in
vitro, an active Cdk5-p35 complex was immunoprecipitated from
brain homogenates and used to phosphorylate recombinant Dab1-His.
Indeed, Dab1 was highly phosphorylated by anti-Cdk5 immunoprecipitated
from brain extracts of wild-type mice (Fig.
2A). In contrast,
immunoprecipitates from brain extracts of Cdk5-deficient littermates
did not yield any significant kinase activity.

View larger version (20K):
[in this window]
[in a new window]
|
Figure 2.
Cdk5-p35 immunoprecipitated from brain
phosphorylates Dab1 in vitro. A, The
Cdk5-p35 complex was immunoprecipitated from detergent lysates of
either Cdk5 / or
Cdk5+/+ P0 brains. The
immunoprecipitates were then used as source of kinase activity to
phosphorylate either full-length Dab1-His or GST fusion proteins
containing Dab1 domains (GST-PTB, residues 1-179; GST-Mid, residues
180-399; GST-CT, residues 400-555) in the presence of
[ -32P]ATP in vitro. Proteins were
separated by SDS-PAGE, transferred to nitrocellulose, and located by
autoradiography. B, In vitro
phosphorylated GST-CT and Dab1-His (from A) were
trypsinized off the membrane, and tryptic fragments were resolved by
alkaline 40% polyacrylamide gel electrophoresis. Autoradiography
revealed two major phosphopeptides (phosphopeptides 1 and 2). C, Schematic representation of
Dab1 domains. The C-terminal region of Dab1 (CT)
gives rise to two phosphopeptides as a result of phosphorylation by
Cdk5-p35. Two serines, serine 491 and serine 515, contain the
consensus sequence for Cdk5 phosphorylation, including proline in +1
position and lysine residue in +3 position.
|
|
To begin to localize the Cdk5 phosphorylation sites on Dab1, we
repeated the in vitro Cdk5 kinase assays using GST fusion proteins representing three distinct regions of Dab1, namely, the PTB
domain (GST-PTB; residues 1-179), the middle region (GST-Mid; residues
180-399), and the C-terminal region (GST-CT; residues 400-555). As
shown in Figure 2A, fusion proteins containing the PTB domain and the middle region of Dab1 were not phosphorylated to any
significant extent. In contrast, the GST fusion product containing the
C-terminal region of Dab1 was phosphorylated to almost the same extent
as full-length Dab1. Therefore, the major sites of in vitro
phosphorylation by Cdk5 are likely to be confined to the C terminus of
Dab1. To confirm this observation, we generated tryptic phosphopeptides
from in vitro phosphorylated Dab1-His and GST-CT and
analyzed them by electrophoretic separation on a 40% acrylamide gel.
As shown in Figure 2B, two major phosphopeptides, phosphopeptides 1 and 2, were clearly resolved, and both were present
in the C-terminal region of Dab1.
Cdk5 exhibits a strong preference for serine and threonine residues
with an adjacent proline and a basic amino acid at the third residue
(Ser/Thr-Pro-X-Arg/Lys) (Songyang et al., 1996 ). Although there are
several Ser-Pro/Thr-Pro sequences present within the C-terminal
domain of Dab1, only two sites, serines 491 and 515, correspond to the
consensus sequence preferred by Cdk5 (Fig. 2C). Both serine
491 and serine 515 are followed by proline in the +1 position and
lysine in the +3 position. Serine 491 is located within a small tryptic
fragment (QSSPSK) comprised of only six amino acids, representing the
smallest possible tryptic peptide that would contain a Cdk5
phosphorylation site within the C-terminal domain of Dab1 (Fig.
2C). Therefore, it is highly probable that phosphopeptide 2 resulted from in vitro phosphorylation of serine 491. The
other putative site for Cdk5 phosphorylation, serine 515, is contained
within a much larger tryptic fragment (SSASHVSDPTADDIFEEGFESPSK). Phosphopeptide 1 is likely a result of phosphorylation of serine 515 within this tryptic fragment. Therefore, our phosphopeptide mapping
analysis was consistent with the hypothesis that Cdk5 preferentially
phosphorylated serines 491 and 515 in vitro.
Anti-PSer491 antibodies recognize Cdk5-catalyzed
Dab1 phosphorylation
We recently used phosphopeptide-specific antibodies to identify
Reelin-induced sites of tyrosine phosphorylation in Dab1 (Keshvara et
al., 2001 ). Therefore, we adopted the same approach to determine whether Dab1 is phosphorylated by Cdk5 in vivo. Although our
phosphopeptide mapping analysis suggested that both serines 491 and 515 are in vitro sites of Cdk5 phosphorylation, we consistently
observed that serine 491 was more highly phosphorylated. Therefore, we chose to generate antibodies against a phosphopeptide corresponding to
this phosphorylation site. The efficacy of the resulting antisera was
determined by Western blotting using lysates from HEK293T cells
transiently transfected with either Dab1 alone or in the presence of
Cdk5 and p35. As shown in Figure
3A, the antiserum preferentially recognized Dab1 when it was cotransfected with Cdk5 and
p35, suggesting that the antibodies specifically reacted with
phosphorylated Dab1. To confirm the specificity of the antibodies, we
generated a mutant of Dab1 in which serine 491 was substituted with an
alanine residue (491A). The antibodies also failed to recognize this
mutant protein, as well as a combination mutant in which both serine
491 and serine 515 of Dab1 were converted to alanine (AA) (Fig.
3B). In contrast, substitution of serine 515 alone (515A)
with alanine did not have any effect on antibody recognition. Western
blots with anti-Dab1 antibodies confirmed that the mutant forms of Dab1
were expressed at equivalent levels. Therefore, these results indicate
that Cdk5 phosphorylates Dab1 on serine 491 in transfected cells and
that the antibodies are highly specific for this phosphoserine
site.

View larger version (17K):
[in this window]
[in a new window]
|
Figure 3.
Characterization of anti-PSer491
phosphopeptide-specific antibodies. A, HEK293T cells
were transfected with either Dab1-HA alone ( ) or Dab1-HA plus
both Cdk5 and p35 (+). Lysates from the transfected cells were
separated by SDS-PAGE, transferred to nitrocellulose, and probed with
antibodies raised against a phosphopeptide encompassing PSer491. To
confirm the presence of Dab1, the membrane was stripped and reprobed
with anti-Dab1 antibodies. B, Wild-type Dab1-HA
(Wt) or mutant forms of Dab1 carrying alanine
substitutions at residues 491 (491A), 515 (515A), or both 491 and 515 (AA) were
transiently expressed in HEK293T cells along with Cdk5 and p35. The
site-specificity of the antibodies was assessed by Western blotting of
the resulting lysates.
|
|
Cdk5-dependent in vivo phosphorylation of Dab1 on
serine 491
To determine whether serine 491 is phosphorylated in
vivo, Dab1 was immunoprecipitated from brain extracts prepared
from E16.5 Cdk5 / ,
Cdk5+/ , or
Cdk5+/+ embryos, and Western blots were
performed using anti-PSer491 antibodies. As shown in Figure
4A, serine 491 was
phosphorylated to the same extent in brain extracts from
Cdk5+/ and
Cdk5+/+. In contrast, phosphorylation of
this serine was not detected in brain extracts from Cdk5-deficient
mice, suggesting that in vivo phosphorylation of serine 491 of Dab1 is catalyzed by Cdk5. Because Cdk5-deficient mice exhibit
neuronal migration defects similar to those observed in
reeler, we asked whether the absence of Cdk5 had any effect
on Reelin signaling. Previously, we demonstrated that tyrosine 198 of
Dab1 is specifically phosphorylated in response to Reelin (Keshvara et
al., 2001 ). Therefore, we used antibodies specific for this
phosphotyrosine (anti-PY198) to investigate Reelin signaling in
Cdk5-deficient mice. Immunoblots with anti-PY198 antibodies revealed
only a modest decrease in phosphorylation of tyrosine 198 in
Cdk5 / mice (Fig.
4A). A characteristic hallmark of a failure in Reelin signaling is the accumulation of Dab1 (Rice et al., 1998 ). Indeed, we
observed a slight increase in Dab1 protein levels in lysates from
Cdk5 / brains (Fig.
4A). Western analysis with anti-actin antibodies confirmed equal sample loading. Thus, these results suggest that there
is a slight but detectable defect in Reelin signaling in Cdk5 / brains at E16.5.

View larger version (31K):
[in this window]
[in a new window]
|
Figure 4.
Cdk5 is required for in vivo
phosphorylation of serine 491. Brain lysates prepared from E16.5
(A) or P0 (B)
Cdk5 / ,
Cdk5 /+, or
Cdk5+/+ embryos were
immunoprecipitated with anti-Dab1 antibodies. The immunoprecipitates
were separated by SDS-PAGE and analyzed by Western blotting using
anti-PSer491, anti-PTyr198, 4G10, or anti-Dab1 antibodies. Western
blots with anti-Cdk5 and anti-actin antibodies were performed on total
lysates.
|
|
At P0, the cortical plate is primarily populated by neurons that
have completed migration in wild-type mice. To determine whether Reelin
signaling is intact at this time in
Cdk5 / mice, we repeated the
above experiments using lysates from P0 Cdk5 / ,
Cdk5 /+, and
Cdk5+/+ brains. As before, we did not
observe any phosphorylation of Dab1 on serine 491 in
Cdk5 / mice (Fig.
4B). In contrast to the situation at E16.5, tyrosine phosphorylation of Dab1 was not detected at P0, suggesting that the
Reelin signaling pathway is severely compromised at this age in
Cdk5 / mice. Indeed, we also observed a
clear accumulation of Dab1 (threefold) in
Cdk5 / mice at P0. In addition, the
electrophoretic mobility of Dab1 from
Cdk5 / mice was distinct from that
observed in extracts from wild-type mice. This mobility shift was most
likely a consequence of hypophosphorylation of Dab1 on both tyrosine
and serine residues. Together, these results suggest that, in
Cdk5 / mice, the Reelin signaling
pathway is intact during the initial stages of cortical plate
formation. However, as the brain develops, Reelin signaling is
progressively impaired in the absence of Cdk5.
Dab1 levels are elevated in ectopically positioned neurons in the
cerebral cortex and cerebellum
Elevated levels of Dab1 are detected in ectopic neurons in
reeler mice (Rice et al., 1998 ). To determine whether the
elevated Dab1 levels detected in Cdk5 /
mice occur specifically in ectopic neurons, we analyzed the
distribution of Dab1 in these mice by immunohistochemistry.
Immunohistochemistry was performed using rabbit antibodies to Dab1 (B3)
on sagittal tissue sections from E18.5 littermates generated by mating
Cdk5+/ mice. As shown in Figure
5A, in wild-type mice, the
cortical plate is positioned above the subplate, and it is
organized into tightly packed layers of radially oriented neuronal cell
bodies. In this case, Dab1 is localized to the cell bodies and the
apical dendrites of postmitotic neurons in the cortical plate (Fig.
5B). In Cdk5 / mice, the
cerebral cortex develops into an early cortical plate (cp)
separated from an ectopic cortical plate (e-cp) located
underneath the subplate (sp) (Fig. 5D).
Immunostaining for Dab1 demonstrated that the ectopic cortical plate
contained increased levels of Dab1 compared with the normally
positioned cortical plate (Fig. 5C). These differences in
Dab1 levels were observed at all levels from lateral to dorsal cerebral
cortex (data not shown).

View larger version (124K):
[in this window]
[in a new window]
|
Figure 5.
Dab1 is elevated in ectopic neurons in the
cerebral cortex and cerebellum. Immunohistochemistry was performed on
cortical and cerebellar tissue sections from E18.5
Cdk5+/+ (A,
B, E, F) and
Cdk5 / (C,
D, G, H) mice.
A, Cresyl violet staining of
Cdk5+/+ mice was used to visualize the
normal arrangement of neurons in the cerebral cortex. B,
In Cdk5+/+ mice, Dab1 is present in
the cell bodies and within the dendrites of cortical plate
(cp) neurons. Low or no immunostaining was observed in
the subplate (sp) and intermediate zone
(iz). D, In the
Cdk5 / cerebral cortex, a thin
cortical plate (cp) forms above a subplate
(sp), and neurons accumulate beneath the subplate in an
ectopic cortical plate (e-cp). C, Dab1
levels appear elevated in neurons that occupy the ectopic cortical
plate (e-cp), located beneath the subplate.
E, Cresyl violet staining of the cerebellum in
Cdk5+/+ mice shows the location of the
Purkinje cell layer (pcl) and the external
germinal layer (egl). F, Dab1 is
present at detectable levels in Purkinje cells aligned in the Purkinje
cell layer (arrows in E and
F). H, In the
Cdk5 / cerebellum, the ectopic
Purkinje cells (e-pc) fail to form a Purkinje cell layer
and instead accumulate close to the ventricle as shown by cresyl violet
staining. G, Dab1 is dramatically elevated in the
ectopic Purkinje cells (arrowheads). Digital images were
captured at identical settings in B and C
and in F and G. Scale bar (in
H), ~100 µm. mz, Marginal
zone; vz, ventricular zone.
|
|
In the wild-type cerebellum at E18.5, Purkinje cells migrate to form a
Purkinje cell layer (pcl) at superficial
positions beneath the external germinal layer (egl)
(Fig. 5E). Dab1 is expressed in Purkinje cells while they
are still migrating (arrows) and in cells that occupy the
Purkinje cell layer (Fig. 5F). Interestingly, the
levels of Dab1 are slightly elevated in small populations of Purkinje
cells caught in the process of migrating into the Purkinje cell layer
(arrows). These populations reside in subcompartments of the
developing cerebellum that have been described previously (Nunzi et
al., 1999 ; Ozol et al., 1999 ). In the
Cdk5 / cerebellum, Purkinje cells fail
to migrate out of deep locations, and instead they accumulate in
ectopic positions near the neuroepithelium (Fig. 5H,
e-pc). Dab1 levels are dramatically elevated in these ectopically located Purkinje cells in the mutant cerebellum (Fig. 5G). Together, these histological studies demonstrate that,
in the absence of Cdk5, Dab1 levels are elevated in specific
populations of neurons located in ectopic positions in the cerebral
cortex and the cerebellum, suggesting that the Reelin signaling pathway is compromised in these cells.
Cdk5-deficient neurons can respond to Reelin
Because the accumulation of hypophosphorylated Dab1 in
Cdk5 / neurons implies that Reelin
signaling is defective, we sought to determine whether the defect in
Reelin signaling is intrinsic to Cdk5-deficient neurons or whether it
arises as an indirect consequence of the ectopic location of these
neurons. Therefore, neurons isolated from E16.5
Cdk5 / and
Cdk5+/+ littermates were treated with
Reelin, and changes in Dab1 tyrosine phosphorylation levels were
monitored by Western blotting using anti-phosphotyrosine antibodies. As
shown in Figure 6, Cdk5-deficient neurons
clearly responded to Reelin by exhibiting a sharp increase in tyrosine
phosphorylation of Dab1. Western analysis using anti-Dab1 and anti-
neuron-specific enolase (NSE) antibodies confirmed equal sample
loading. Thus, these results demonstrate that Cdk5 activity is not
required for Reelin-induced tyrosine phosphorylation of Dab1.

View larger version (80K):
[in this window]
[in a new window]
|
Figure 6.
Cdk5 is not required for Reelin-induced tyrosine
phosphorylation of Dab1. Neurons isolated from E16.5
Cdk5 / or
Cdk5+/+ embryos were suspended in DMEM
alone (Con) or Reelin-enriched DMEM
(Reln). Treated neurons were then lysed and
immunoprecipitated with anti-Dab1 antibodies. The immunoprecipitates
were separated by SDS-PAGE and transferred to nitrocellulose, and
Western blots were performed using 4G10 anti-phosphotyrosine
(PTyr) or anti-Dab1 (Dab1) antibodies.
Lysates were also probed with anti-NSE antibodies to confirm equal
sample loading.
|
|
Serine phosphorylation of Dab1 occurs independently of Reelin
Because Reelin-induced tyrosine phosphorylation of Dab1 was not
affected in Cdk5 / neurons, we
cannot place Cdk5 upstream of Reelin in a linear signaling pathway.
Therefore, we investigated the possibility that Cdk5-mediated serine
phosphorylation of Dab1 lies downstream of Reelin. Western analysis,
using anti-phosphotyrosine and anti-Pser491 antibodies, was performed
on Dab1 immunoprecipitated from brain extracts prepared from E14.5
reeler or wild-type embryos. As observed previously,
Dab1 levels were significantly elevated in reeler brains, whereas tyrosine phosphorylation was barely detectable (Rice et
al., 1998 ; Howell et al., 1999a ) (Fig.
7A). In contrast, there
was no apparent change in the stoichiometry of phosphorylation of
serine 491 in reeler. To further examine the effect of
Reelin stimulation on serine phosphorylation of Dab1, neurons isolated from E16.5 reeler brains were treated in
vitro with exogenous Reelin for 15 min at 37°C. As expected,
Reelin stimulation resulted in a sharp increase in tyrosine
phosphorylation of Dab1 (Fig. 7B). In contrast, serine
491 was constitutively phosphorylated in these neurons, and exposure to
Reelin did not cause any noticeable change. These results suggest that
Cdk5-mediated serine phosphorylation of Dab1 occurs independently of
Reelin.

View larger version (26K):
[in this window]
[in a new window]
|
Figure 7.
Phosphorylation of Dab1 on serine 491 does not
require Reelin signaling. A, Brain lysates prepared from
E14.5 reeler (rl/rl) or wild-type
(wt) littermates were immunoprecipitated with
anti-Dab1 antibodies. The immunoprecipitates were then separated by
SDS-PAGE, transferred to nitrocellulose, and probed with anti-Dab1,
anti-phosphotyrosine, or anti-PSer491 antibodies. B,
E16.5 reeler neurons were either left untreated
(Con) or treated with Reelin (Reln), and
phosphorylation was determined by anti-phosphotyrosine and anti-PSer491
antibodies as before.
|
|
Phosphorylation of Dab1 during development
To gain some understanding of the role of Cdk5-mediated serine
phosphorylation of Dab1 during the course of brain development, we
compared serine and tyrosine phosphorylation of Dab1 in E15.5, P0, P3,
P8, P16, and P42 brains. As shown in Figure
8., Dab1 was phosphorylated on tyrosine
only in the embryonic and early postnatal brains, and no significant
tyrosine phosphorylation of Dab1 was observed after postnatal day 16. In contrast, phosphorylation of serine 491 was present in both
embryonic and adult tissue. Indeed, serine phosphorylation of Dab1
closely matched the pattern of Cdk5 expression and activity, which has
been shown to be very low during embryogenesis but to peak in the adult
(Tsai et al., 1993 ).

View larger version (32K):
[in this window]
[in a new window]
|
Figure 8.
Changes in Dab1 serine and tyrosine
phosphorylation during development. Brain lysates were prepared from
E15.5, P0, P3, P8, P16, or P42 wild-type mice. Anti-Dab1
immunoprecipitates from these lysates were separated by SDS-PAGE and
transferred to nitrocellulose. The membrane was sequentially probed
with anti-phosphotyrosine, anti-PSer491, and anti-Dab1
antibodies.
|
|
 |
DISCUSSION |
Reelin and Cdk5 have emerged as critical components of two
signaling pathways that regulate neuronal migration during mammalian brain development (Rice and Curran, 2001 ). Mice with disruptions in
reelin, dab1, or both vldlr and
apoER2 exhibit the reeler phenotype, which led to
the placement of these molecules within a signaling pathway
(D'Arcangelo et al., 1995 ; Howell et al., 1997b ; Sheldon et al., 1997 ;
Trommsdorff et al., 1999 ). The lamination defects observed in mice
deficient in Cdk5 (Ohshima et al., 1996 ; Gilmore et al., 1998 ; Ohshima
et al., 1999 ), p35 (Kwon and Tsai, 1998 ), or both p35 and p39 (Ko et
al., 2001 ) are less severe but similar to those found in
reeler, suggesting that there may be a cross-talk between
the Reelin and Cdk5 pathways. Therefore, we hypothesized that such a
biochemical link between the two pathways might involve direct
phosphorylation of Dab1 by Cdk5. Here we show that Cdk5 phosphorylates
Dab1 on serine 491 in vivo.
Our findings present an interesting possibility that Dab1 may serve as
a point of convergence for the Reelin and Cdk5 pathways. Dab1 contains
several features of an adapter molecule that may be involved in more
than one pathway. The PTB domain within its N-terminal region anchors
Dab1 to NPxY sequence motifs present within the cytoplasmic domains of
various receptors, including the lipoprotein receptors VLDLR and ApoER2
(Trommsdorff et al., 1998 ) and the amyloid peptide precursor family of
proteins (Homayouni et al., 1999 ; Howell et al., 1999b ). Dab1 contains
several tyrosine residues that are critical for its function in the
Reelin pathway (Howell et al., 2000 ), and at least two of these
tyrosines are phosphorylated in response to Reelin stimulation
(Keshvara et al., 2001 ). Reelin-induced phosphorylation of these
tyrosines is likely to result in creation of docking sites on Dab1 for
recruitment of signaling molecules containing Src homology 2 (SH2)
domains (Songyang et al., 1993 ). At least in vitro, tyrosine
phosphorylated Dab1 has been shown to interact with SH2
domain-containing proteins (Howell et al., 1997a ). Therefore, Dab1 is
likely to serve as a scaffold for assembly of a signaling complex that
would couple an upstream signal from Reelin to the molecular machinery
involved in cell positioning. Cdk5-mediated serine phosphorylation
could potentially modulate the function of the Dab1-associated
signaling complex. For example, it is possible that phosphorylated
serine residues could serve to recruit additional signaling proteins containing phosphoserine protein-interaction modules, similar to the
phosphoserine binding exhibited by 14-3-3 proteins (Yaffe and Elia,
2001 ). Alternatively, phosphorylation on serine may induce a
conformational change in Dab1 that might influence its interaction with
downstream effector molecules.
Unlike tyrosine phosphorylation of Dab1, phosphorylation of serine 491 by Cdk5 occurs independently of the presence of Reelin. Therefore,
Reelin is unlikely to play a role in regulating Cdk5 activity.
Conversely, Cdk5-deficient neurons exhibit a normal Reelin response,
whereby Dab1 is tyrosine phosphorylated as a result of exposure to
Reelin. Therefore, Cdk5-mediated serine phosphorylation of Dab1 is not
required for the Reelin-response. Also, examination of brain lysates
from different ages showed that tyrosine phosphorylation of Dab1 is
restricted to embryonic and early postnatal brains, whereas serine
phosphorylation of Dab1 occurs throughout development and in the adult.
Together, these results are consistent with a model in which Reelin and Cdk5 are components of two distinct signaling pathways. Indeed, recent
analysis of mice lacking both p35 and Dab1 revealed additive defects in
the cerebellum and in the hippocampus, suggesting that neuronal
positioning is regulated by contributions from both of these pathways
(Ohshima et al., 2001 ). Nevertheless, a cross-talk between the two
pathways, through serine phosphorylation of Dab1, may represent an
important mechanism for fine tuning of neuronal migration.
Persistence of serine phosphorylation of Dab1 in adult mice suggests a
potential role for Cdk5-mediated Dab1 phosphorylation in neuronal
functions that occur after the completion of cell positioning. Indeed,
the Reelin signaling pathway has been implicated in synaptogenesis
(Borrell et al., 1999 ; Rice et al., 2001 ). Therefore, it is possible
that serine phosphorylation of Dab1 may play a role in such
post-positioning functions. It is not known whether Dab1 is involved in
other cellular processes. However, in light of our results indicating a
biochemical link between Cdk5 and Dab1, it will now be important to
investigate a potential role for Dab1 in events that require Cdk5. Cdk5
is thought to contribute to the pathology of neurodegenerative
disorders, such as Alzheimer's disease (Patrick et al., 1999 ) and
amyotrophic lateral sclerosis (Nguyen et al., 2001 ). Cdk5 is also
implicated in the regulation of numerous other cellular events,
including neurite extension (Nikolic et al., 1996 ), cell adhesion
(Homayouni and Curran, 2000 ; Kwon et al., 2000 ), and axonal transport
(Niethammer et al., 2000 ; Sasaki et al., 2000 ; Wynshaw-Boris and
Gambello, 2001 ). Therefore, given the overlap of the Cdk5 and Dab1
expression patterns, it is possible that Dab1 may also participate in
these cellular processes.
Dab1 was found to accumulate in a hypophosphorylated form in
Cdk5 / neurons. Decreased tyrosine
phosphorylation of Dab1 and its subsequent accumulation were very
slight at E16.5 in Cdk5 / brains, but
these changes became dramatic by P0. One possible interpretation of
this result is that Cdk5 / neurons
suffer from an intrinsic biochemical defect that prevents Reelin-induced Dab1 tyrosine phosphorylation. However, this is unlikely, because cultured Cdk5 /
neurons exhibited a normal Dab1 tyrosine phosphorylation response when
treated with exogenous Reelin. When Dab1 expression was analyzed by
immunohistochemistry, Dab1 accumulation was particularly prevalent in
neurons located in deeper layers of the cerebral cortex and the
cerebellum. Previous neuroanatomic analysis of Cdk5- and p35-deficient mice demonstrated that the first cohorts of neurons are able to migrate
past subplate neurons, but later-born neurons fail to overtake their
predecessors (Gilmore et al., 1998 ; Kwon and Tsai, 1998 ). These
subsequent failures in migration lead to ectopic accumulation of
neurons beneath the subplate. Similarly, in the cerebellum, Purkinje
cells fail to migrate outward to form the Purkinje cell layer, and
instead they are clustered in deep regions of the cerebellum (Ohshima
et al., 1999 ). The accumulation of Dab1 in
Cdk5 / mice is confined to these
ectopic neurons arrested deep within the cortex and the cerebellum. The
most straightforward interpretation of our results is that, in the
absence of Cdk5, ectopic neurons fail to reach the source of Reelin,
which is expressed in the marginal zone of the cortex and in the
external germinal layer and nuclear transitory zone of the cerebellum
in the developing brain. This effect becomes progressively more severe
at later stages of development when neurons have to traverse greater
distances to contact Reelin. Therefore, it is unlikely that the
diminished Reelin signaling in Cdk5 /
neurons during late embryogenesis is attributable to an
intrinsic defect in the Reelin pathway within these neurons, but rather it is a consequence of their ectopic location. This hypothesis can be
tested by expressing Reelin in locations more proximal to the ectopic
neurons of the cerebral cortex and cerebellum in Cdk5 / mice.
We identified serine 491 of Dab1 as a Cdk5-dependent site of in
vivo phosphorylation. However, we cannot rule out the possibility that there are other Cdk5 phosphorylation sites in Dab1. Indeed, our
phosphopeptide mapping analysis suggested that Cdk5 also phosphorylates serine 515 of Dab1 in vitro. Nevertheless, antibodies
against phosphoserine 491 of Dab1 provide a valuable marker for Cdk5
activity in vivo, and they can be used to further
investigate the role of Cdk5 in neural functions within cells that
express Dab1. Although the functional significance of Cdk5-catalyzed
phosphorylation of Dab1 is not yet clear, our results suggest that
Reelin and Cdk5 are components of two distinct signaling pathways that
may converge on Dab1. Cdk5-mediated serine phosphorylation of Dab1 may
serve to modulate signaling events initiated by Reelin that lie
downstream of Dab1 tyrosine phosphorylation. Alternatively, serine
phosphorylation might point to a potential role for Dab1 beyond the
Reelin signaling pathway. A comprehensive approach involving a
combination of genetic and biochemical techniques will now be required
to clarify the biochemical and neuroanatomical consequences of
Cdk5-mediated serine phosphorylation of Dab1.
 |
FOOTNOTES |
Received Feb. 8, 2002; revised April 1, 2002; accepted April 1, 2002.
This work was supported in part by National Institutes of Health Cancer
Center Support CORE Grant P30 CA21765, National Institutes of
Health/National Institute of Neurological Disorders and Stroke Grant
RO1-NS36558 (T.C.), the American Lebanese Syrian Associated Charities,
and Human Frontiers Science Program Grant RG67/98. We thank Dr. Ashok
Kulkarni for the Cdk5 mutant mice, Dr. Li-Huei Tsai for Cdk5 and p35
expression plasmids, Dr. Jonathan Cooper for B3 anti-Dab1 antibodies,
and Dr. Hee-Won Park for purified His-tagged Dab1. We are also thankful
to Dr. Li-Huei Tsai and Dr. Janet Volker for helpful discussions.
Correspondence should be addressed to Dr. Tom Curran, Department of
Developmental Neurobiology, St. Jude Children's Research Hospital, 332 North Lauderdale, Memphis, TN 38105. E-mail: fos1{at}aol.com.
 |
REFERENCES |
-
Borrell V,
Del Rio JA,
Alcantara S,
Derer M,
Martinez A,
D'Arcangelo G,
Nakajima K,
Mikoshiba K,
Derer P,
Curran T,
Soriano E
(1999)
Reelin regulates the development and synaptogenesis of the layer-specific entorhino-hippocampal connections.
J Neurosci
19:1345-1358[Abstract/Free Full Text].
-
Chae T,
Kwon YT,
Bronson R,
Dikkes P LiE,
Tsai LH
(1997)
Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality.
Neuron
18:29-42[Web of Science][Medline].
-
D'Arcangelo G,
Curran T
(1998)
Reeler: new tales on an old mutant mouse.
BioEssays
20:235-244[Web of Science][Medline].
-
D'Arcangelo G,
Miao GG,
Chen SC,
Soares HD,
Morgan JI,
Curran T
(1995)
A protein related to extracellular matrix proteins deleted in the mouse mutant reeler.
Nature
374:719-723[Medline].
-
D'Arcangelo G,
Homayouni R,
Keshvara L,
Rice DS,
Sheldon M,
Curran T
(1999)
Reelin is a ligand for lipoprotein receptors.
Neuron
24:471-479[Web of Science][Medline].
-
Dhavan R,
Tsai LH
(2001)
A decade of cdk5.
Nat Rev Mol Cell Biol
2:749-759[Web of Science][Medline].
-
Gilmore EC,
Ohshima T,
Goffinet AM,
Kulkarni AB,
Herrup K
(1998)
Cyclin-dependent kinase 5-deficient mice demonstrate novel developmental arrest in cerebral cortex.
J Neurosci
18:6370-6377[Abstract/Free Full Text].
-
Hiesberger T,
Trommsdorff M,
Howell BW,
Goffinet A,
Mumby MC,
Cooper JA,
Herz J
(1999)
Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation.
Neuron
24:481-489[Web of Science][Medline].
-
Homayouni R,
Curran T
(2000)
Cortical development: Cdk5 gets into sticky situations.
Curr Biol
10:R331-R334[Web of Science][Medline].
-
Homayouni R,
Rice DS,
Sheldon M,
Curran T
(1999)
Disabled-1 binds to the cytoplasmic domain of amyloid precursor-like protein 1.
J Neurosci
19:7507-7515[Abstract/Free Full Text].
-
Howell BW,
Gertler FB,
Cooper JA
(1997a)
Mouse disabled (mDab1): a Src binding protein implicated in neuronal development.
EMBO J
16:121-132[Web of Science][Medline].
-
Howell BW,
Hawkes R,
Soriano P,
Cooper JA
(1997b)
Neuronal position in the developing brain is regulated by mouse disabled-1.
Nature
389:733-737[Medline].
-
Howell BW,
Herrick TM,
Cooper JA
(1999a)
Reelin-induced tryosine phosphorylation of disabled 1 during neuronal positioning.
Genes Dev
13:643-648[Abstract/Free Full Text].
-
Howell BW,
Lanier LM,
Frank R,
Gertler FB,
Cooper JA
(1999b)
The disabled 1 phosphotyrosine-binding domain binds to the internalization signals of transmembrane glycoproteins and to phospholipids.
Mol Cell Biol
19:5179-5188[Abstract/Free Full Text].
-
Howell BW,
Herrick TM,
Hildebrand JD,
Zhang Y,
Cooper JA
(2000)
Dab1 tyrosine phosphorylation sites relay positional signals during mouse brain development.
Curr Biol
10:877-885[Web of Science][Medline].
-
Keshvara L,
Benhayon D,
Magdaleno S,
Curran T
(2001)
Identification of reelin-induced sites of tyrosyl phosphorylation on disabled 1.
J Biol Chem
276:16008-16014[Abstract/Free Full Text].
-
Ko J,
Humbert S,
Bronson RT,
Takahashi S,
Kulkarni AB LiE,
Tsai LH
(2001)
p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment.
J Neurosci
21:6758-6771[Abstract/Free Full Text].
-
Kwon YT,
Tsai LH
(1998)
A novel disruption of cortical development in p35(
/ ) mice distinct from reeler.
J Comp Neurol
395:510-522[Web of Science][Medline]. -
Kwon YT,
Gupta A,
Zhou Y,
Nikolic M,
Tsai LH
(2000)
Regulation of N-cadherin-mediated adhesion by the p35-Cdk5 kinase.
Curr Biol
10:363-372[Web of Science][Medline].
-
Lew J,
Huang QQ QiZ,
Winkfein RJ,
Aebersold R,
Hunt T,
Wang JH
(1994)
A brain-specific activator of cyclin-dependent kinase 5.
Nature
371:423-426[Medline].
-
Nguyen MD,
Lariviere RC,
Julien JP
(2001)
Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions.
Neuron
30:135-147[Web of Science][Medline].
-
Niethammer M,
Smith DS,
Ayala R,
Peng J,
Ko J,
Lee MS,
Morabito M,
Tsai LH
(2000)
NUDEL is a novel Cdk5 substrate that associates with LIS1 and cytoplasmic dynein.
Neuron
28:697-711[Web of Science][Medline].
-
Nikolic M,
Dudek H,
Kwon YT,
Ramos YF,
Tsai LH
(1996)
The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation.
Genes Dev
10:816-825[Abstract/Free Full Text].
-
Nunzi MG,
Grillo M,
Margolis FL,
Mugnaini E
(1999)
Compartmental organization of Purkinje cells in the mature and developing mouse cerebellum as revealed by an olfactory marker protein-lacZ transgene.
J Comp Neurol
404:97-113[Medline].
-
Ohshima T,
Ward JM,
Huh CG,
Longenecker G,
Veeranna,
Pant HC,
Brady RO,
Martin LJ,
Kulkarni AB
(1996)
Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death.
Proc Natl Acad Sci USA
93:11173-11178[Abstract/Free Full Text].
-
Ohshima T,
Gilmore EC,
Longenecker G,
Jacobowitz DM,
Brady RO,
Herrup K,
Kulkarni AB
(1999)
Migration defects of cdk5(
/ ) neurons in the developing cerebellum is cell autonomous.
J Neurosci
19:6017-6026[Abstract/Free Full Text]. -
Ohshima T,
Ogawa M,
Veeranna,
Hirasawa M,
Longenecker G,
Ishiguro K,
Pant HC,
Brady RO,
Kulkarni AB,
Mikoshiba K
(2001)
Synergistic contributions of cyclin-dependant kinase 5/p35 and Reelin/Dab1 to the positioning of cortical neurons in the developing mouse brain.
Proc Natl Acad Sci USA
98:2764-2769[Abstract/Free Full Text].
-
Ozol K,
Hayden JM,
Oberdick J,
Hawkes R
(1999)
Transverse zones in the vermis of the mouse cerebellum.
J Comp Neurol
412:95-111[Web of Science][Medline].
-
Patrick GN,
Zukerberg L,
Nikolic M,
de la Monte S,
Dikkes P,
Tsai LH
(1999)
Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration.
Nature
402:615-622[Medline].
-
Rice DS,
Curran T
(2001)
Role of the Reelin signaling pathway in central nervous system development.
Annu Rev Neurosci
24:1005-1039[Web of Science][Medline].
-
Rice DS,
Sheldon M,
D'Arcangelo G,
Nakajima K,
Goldowitz D,
Curran T
(1998)
Disabled-1 acts downstream of Reelin in a signaling pathway that controls laminar organization in the mammalian brain.
Development
125:3719-3729[Abstract].
-
Rice DS,
Nusinowitz S,
Azimi AM,
Martinez A,
Soriano E,
Curran T
(2001)
The reelin pathway modulates the structure and function of retinal synaptic circuitry.
Neuron
31:929-941[Web of Science][Medline].
-
Sasaki S,
Shionoya A,
Ishida M,
Gambello MJ,
Yingling J,
Wynshaw-Boris A,
Hirotsune S
(2000)
A LIS1/NUDEL/cytoplasmic dynein heavy chain complex in the developing and adult nervous system.
Neuron
28:681-696[Web of Science][Medline].
-
Sheldon M,
Rice DS,
D'Arcangelo G,
Yoneshima H,
Nakajima K,
Mikoshiba K,
Howell BW,
Cooper JA,
Goldowitz D,
Curran T
(1997)
Scrambler and yotari disrupt the disabled gene and produce a reeler-like phenotype in mice.
Nature
389:730-733[Medline].
-
Songyang Z,
Shoelson SE,
Chaudhuri M,
Gish G,
Pawson T,
Haser WG,
King F,
Roberts T,
Ratnofsky S,
Lechleider RJ,
Neel BG,
Birge RB,
Fajardo JE,
Chou MM,
Hanafusa H,
Schaffhausen B,
Cantley LC
(1993)
SH2 domains recognize specific phosphopeptide sequences.
Cell
72:767-778[Web of Science][Medline].
-
Songyang Z,
Lu KP,
Kwon YT,
Tsai LH,
Filhol O,
Cochet C,
Brickey DA,
Soderling TR,
Bartleson C,
Graves DJ,
DeMaggio AJ,
Hoekstra MF,
Blenis J,
Hunter T,
Cantley LC
(1996)
A structural basis for substrate specificities of protein Ser/Thr kinases: primary sequence preference of casein kinases I, II, NIMA, phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and Erk1.
Mol Cell Biol
16:6486-6493[Abstract].
-
Tang D,
Yeung J,
Lee KY,
Matsushita M,
Matsui H,
Tomizawa K,
Hatase O,
Wang JH
(1995)
An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator.
J Biol Chem
270:26897-26903[Abstract/Free Full Text].
-
Trommsdorff M,
Borg JP,
Margolis B,
Herz J
(1998)
Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein.
J Biol Chem
273:33556-33560[Abstract/Free Full Text].
-
Trommsdorff M,
Gotthardt M,
Hiesberger T,
Shelton J,
Stockinger W,
Nimpf J,
Hammer RE,
Richardson JA,
Herz J
(1999)
Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2.
Cell
97:689-701[Web of Science][Medline].
-
Tsai LH,
Takahashi T,
Caviness Jr VS,
Harlow E
(1993)
Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system.
Development
119:1029-1040[Abstract].
-
Tsai LH,
Delalle I,
Caviness Jr VS,
Chae T,
Harlow E
(1994)
p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5.
Nature
371:419-423[Medline].
-
Wynshaw-Boris A,
Gambello MJ
(2001)
LIS1 and dynein motor function in neuronal migration and development.
Genes Dev
15:639-651[Free Full Text].
-
Yaffe MB,
Elia AE
(2001)
Phosphoserine/threonine-binding domains.
Curr Opin Cell Biol
13:131-138[Web of Science][Medline].
Copyright © 2002 Society for Neuroscience 0270-6474/02/22124869-09$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
T.-J. Park and T. Curran
Crk and Crk-Like Play Essential Overlapping Roles Downstream of Disabled-1 in the Reelin Pathway
J. Neurosci.,
December 10, 2008;
28(50):
13551 - 13562.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Sato, M. Taoka, N. Sugiyama, K.-i. Kubo, T. Fuchigami, A. Asada, T. Saito, K. Nakajima, T. Isobe, and S.-i. Hisanaga
Regulation of the interaction of Disabled-1 with CIN85 by phosphorylation with Cyclin-dependent kinase 5.
Genes Cells,
December 1, 2007;
12(12):
1315 - 1327.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T.-J. Park, K. Boyd, and T. Curran
Cardiovascular and Craniofacial Defects in Crk-Null Mice.
Mol. Cell. Biol.,
August 1, 2006;
26(16):
6272 - 6282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Strock, J.-I. Park, E. K. Nakakura, G. S. Bova, J. T. Isaacs, D. W. Ball, and B. D. Nelkin
Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells.
Cancer Res.,
August 1, 2006;
66(15):
7509 - 7515.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Pramatarova, P. G. Ochalski, C.-H. Lee, and B. W. Howell
Mouse Disabled 1 Regulates the Nuclear Position of Neurons in a Drosophila Eye Model
Mol. Cell. Biol.,
February 15, 2006;
26(4):
1510 - 1517.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Gonzalez-Billault, J. A. Del Rio, J. M. Urena, E. M. Jimenez-Mateos, M. J. Barallobre, M. Pascual, L. Pujadas, S. Simo, A. L. Torre, R. Gavin, et al.
A role of MAP1B in Reelin-dependent Neuronal Migration
Cereb Cortex,
August 1, 2005;
15(8):
1134 - 1145.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Homayouni, K. Heinrich, L. Wei, and M. W. Berry
Gene clustering by Latent Semantic Indexing of MEDLINE abstracts
Bioinformatics,
January 1, 2005;
21(1):
104 - 115.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. H. Bock, Y. Jossin, P. May, O. Bergner, and J. Herz
Apolipoprotein E Receptors Are Required for Reelin-induced Proteasomal Degradation of the Neuronal Adaptor Protein Disabled-1
J. Biol. Chem.,
August 6, 2004;
279(32):
33471 - 33479.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Louvi, S. S. Sisodia, and E. A. Grove
Presenilin 1 in migration and morphogenesis in the central nervous system
Development,
July 1, 2004;
131(13):
3093 - 3105.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Beffert, E. J. Weeber, G. Morfini, J. Ko, S. T. Brady, L.-H. Tsai, J. D. Sweatt, and J. Herz
Reelin and Cyclin-Dependent Kinase 5-Dependent Signals Cooperate in Regulating Neuronal Migration and Synaptic Transmission
J. Neurosci.,
February 25, 2004;
24(8):
1897 - 1906.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Hammond, L.-H. Tsai, and S.-S. Tan
Control of Cortical Neuron Migration and Layering: Cell and Non Cell-Autonomous Effects of p35
J. Neurosci.,
January 14, 2004;
24(2):
576 - 587.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Arnaud, B. A. Ballif, and J. A. Cooper
Regulation of Protein Tyrosine Kinase Signaling by Substrate Degradation during Brain Development
Mol. Cell. Biol.,
December 15, 2003;
23(24):
9293 - 9302.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. H. Bock, Y. Jossin, P. Liu, E. Forster, P. May, A. M. Goffinet, and J. Herz
Phosphatidylinositol 3-Kinase Interacts with the Adaptor Protein Dab1 in Response to Reelin Signaling and Is Required for Normal Cortical Lamination
J. Biol. Chem.,
October 3, 2003;
278(40):
38772 - 38779.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kesavapany, K.-F. Lau, S. Ackerley, S. J. Banner, S. J. A. Shemilt, J. D. Cooper, P. N. Leigh, C. E. Shaw, D. M. McLoughlin, and C. C. J. Miller
Identification of a Novel, Membrane-Associated Neuronal Kinase, Cyclin-Dependent Kinase 5/p35-Regulated Kinase
J. Neurosci.,
June 15, 2003;
23(12):
4975 - 4983.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Jossin, I. Bar, N. Ignatova, F. Tissir, C. L. de Rouvroit, and A. M. Goffinet
The Reelin Signaling Pathway: Some Recent Developments
Cereb Cortex,
June 1, 2003;
13(6):
627 - 633.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Patzke, U. Maddineni, R. Ayala, M. Morabito, J. Volker, P. Dikkes, M. K. Ahlijanian, and L.-H. Tsai
Partial Rescue of the p35-/- Brain Phenotype by Low Expression of a Neuronal-Specific Enolase p25 Transgene
J. Neurosci.,
April 1, 2003;
23(7):
2769 - 2778.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|